Table 2.

Characteristics of patients with MIBC.

Characteristics	No. of patients	Good Responder (n = 36)	Non-Good Responder (n = 34)	P value
Age* (years old, mean ± SD)	61.9 ± 8.3	61.1 ± 9.1	62.8 ± 7.4	0.39
Gender
Male	62	30 (83%)	32 (94%)	0.30
Female	8	6 (17%)	2 (6%)
Number of lesions				0.99
Solitary	48	24 (64%)	24 (60%)
Multiple	22	12 (36%)	10 (40%)
Clinical T stage (cT)				0.004
cT2	21	17 (55%)	4 (28%)
cT3	43	17(39%)	26 (64%)
cT4a	6	2 (6%)	4 (8%)
Histological grade				0.28
Low grade	14	9 (36%)	5 (36%)
High grade	56	27 (64%)	29 (64%)
NAC courses				0.38
2	18	7 (19%)	11 (32%)
3	32	19 (53%)	13 (38%)
4	20	10 (28%)	10 (30%)
Surgery				N/A
Radical cystectomy + PLND	23	1 (12%)	22 (60%)
Partial cystectomy + PLND	9	3 (21%)	6 (12%)
TURBT+CRT	38	32 (67%)	6 (28%)
Pathological Stages (pT)				N/A
pT0	2	2 (5%)
pTa	1	1 (3%)
pTis	1	1 (3%)
pT1	32	32 (89%)
pT2	13		13 (38%)
pT3	15		15 (44%)
pT4	6		6 (18%)

Except where indicated, data include number of participants, with percentages in parentheses. SD, standard deviation, MIBC,muscle-invasive bladder cancer; TURBT,transurethral resection of bladder tumor; NAC,neoadjuvant chemotherapy; CRT, chemoradiotherapy; PLND,pelvic lymphadenectomy; N/A,not applicable; RC, radical cystectomy.

*Data are presented as mean ± standard deviation.